Schedule/Additional Infoexpand_more
Gynecologic and Obstetric Pathology: A Comprehensive Update - 2020
April 6-9, 2020
Add to Calendar Download
Driskill Hotel
604 Brazos St Austin, TX 78701-3212 

What’s New and Exciting in 2020!

  • Pitfalls, challenges and controversies in the 8th edition AJCC staging criteria for gynecologic tumors.
  • New approaches to evaluating endocervical adenocarcinoma, including the new IECC classification system and the Silva pattern-based system for reporting invasiveness.
  • Updates on non-HPV associated squamous and glandular tumors of the cervix and vulva.
  • Emerging roles for molecular classification of uterine mesenchymal tumors and endometrial cancer.
  • Expanded role of digital slide case presentations and audience-participation.



This is a practical and comprehensive update of gynecologic and obstetric pathology, designed for practicing pathologists, emphasizing clinically-relevant, evidence-based pathologic evaluation and reporting. The course covers benign and neoplastic pathology of the female genital organs (endometrium, myometrium, cervix, vulva, ovary, fallopian tube) as well as gestational trophoblastic disease, pathology of the female peritoneum, pathology of the placenta, and gynecologic cytopathology.


In addition to reviewing practical strategies for navigating common diagnostic problems and pitfalls, the course will highlight recent diagnostic advances in tumor classification, immunohistochemistry, and diagnostic molecular tests that can be used in routine practice today. Gross specimen management will be discussed, particularly for the placenta, sentinel lymph nodes, and fallopian tubes. Reporting guidelines from the College of American Pathologists and staging guidelines from the American Joint Committee on Cancer will be highlighted, including practical strategies for reporting/staging cases that are challenging or controversial.


The course will also review the rapidly expanding spectrum of gynecologic hereditary tumor syndromes that exhibit distinctive morphologic features and the role of the pathologist in referring the patient for further genetic risk assessment. In cases for which there is little or no evidence-based literature, practical recommendations for reporting will be discussed. The course design strives to promoting patient safety and improving patient care. The format of the course is a mixture of traditional lectures and audience-participation case discussions using digital slides that are presented by the speakers from the podium.


Click here for course schedule


Credits:   30.0 CME Credits, 8.0 SAMs CME Credits


Following this course, you will be able to:

  • Classify common neoplasms, precursor lesions and their benign mimics using the current World Health Organization classification system for...
  • List Price: $1,455.00
  • Member Price: $1,119.00
Want to save more?
Log into see if you qualify for a lower rate.
Members save $336.00 or more Join